Incannex healthcare inc. reports fiscal first quarter 2025 financial results and business updates

New york and melbourne, australia, nov. 14, 2024 (globe newswire) -- incannex healthcare inc. (nasdaq: ixhl), (incannex), a clinical-stage biopharmaceutical company developing innovative medicines for people with chronic diseases and significant unmet medical needs, today reported fiscal first quarter financial results and provided business highlights for the quarter ended september 30, 2024.
IXHL Ratings Summary
Quant
IXHL Quant Ranking
Sector
Industry
Quant Rating
Quant Score